BioBank Japan PheWeb (PheWeb.jp)
This website releases genome-wide association study (GWAS) summary statistics of the BioBank Japan Project (BBJ). We provide GWAS results in the Japanese population (mainly from BBJ) using the PheWeb platform, with public access to the full summary statistics.
BBJ is a prospective genome biobank that collaboratively collected DNA and serum samples from 12 medical institutions in Japan, managed by the Institute of Medical Science, the University of Tokyo. BBJ has recruited approximately 260,000 participants, mainly of Japanese ancestry. All study participants had been diagnosed with one or more of 47 target diseases. RIKEN Center for Integrative Medical Sciences contributed to genotyping of the BBJ samples.
November 18, 2022: 14 new GWAS results from Shirai, Y., et al. (2022), Sonehara, K., et al. (2022), and Namkoong, H. & Edahiro, R., et al. (2022).
Phenotypes include intracranial germ cell tumors, COVID-19 phenotypes (e.g., severe COVID-19 aged less than 65), and multi-trait meta-analysis of autoimmune and/or allergy diseases.
March 12, 2022: cis-miRNA-eQTL results from Sonehara, K. & Sakaue, S., et al. (2022).
Raw data are available for download on the NBDC website.
December 21, 2021: 10 additional GWAS results from Kanai, M., et al. (2021).
Fine-mapping results of 79 traits are also available for download.
September 30, 2021: Sakaue, S. & Kanai, M., et al. (2021) is now published at Nature Genetics.
The article was selected as a cover of the issue.
March 12, 2021: First Release!
We added 220 GWAS results from Sakaue, S. & Kanai, M., et al. (2021), Sakaue, S., et al. (2021), and Okada, Y., et al. (2014).